Median DOR of 44.3 months supports durability of response 4-year overall survival rate of 35.3% and median OS of 28.2 months suggest meaningful long-term survival Long-term survival of 42+ – 60+ months observed among complete responders SAN DIEGO, Oct. 23, 2026 /PRNewswire/ — Rakuten…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
